Adverse effects associated with second-generation antipsychotic long-acting injection treatment: a comprehensive systematic review.

@article{Gentile2013AdverseEA,
  title={Adverse effects associated with second-generation antipsychotic long-acting injection treatment: a comprehensive systematic review.},
  author={Salvatore Gentile},
  journal={Pharmacotherapy},
  year={2013},
  volume={33 10},
  pages={
          1087-106
        }
}
As second-generation antipsychotic long-acting injections (SGA-LAIs) are rapidly replacing depot first-generation antipsychotics as first-line agents in treating schizophrenia spectrum disorders, a systematic assessment of their adverse effects is timely. English-language, peer-reviewed articles reporting original data on the safety and tolerability of SGA-LAIs were identified electronically by searching the MEDLINE, EMBASE, PsycINFO, and DARE databases and the Cochrane Library (January 2001… CONTINUE READING
BETA

Similar Papers

Citations

Publications citing this paper.
SHOWING 1-10 OF 20 CITATIONS

Safety concerns associated with second-generation antipsychotic long-acting injection treatment. A systematic update.

  • Hormone molecular biology and clinical investigation
  • 2017
VIEW 8 EXCERPTS
CITES RESULTS, BACKGROUND & METHODS
HIGHLY INFLUENCED